Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Healthcare
/
Drägerwerk KGaA
DRW3
Drägerwerk KGaA
Regulatory Burdens And Procurement Consolidation Will Weaken Operating Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
17 Jul 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€63.00
9.4% overvalued
intrinsic discount
09 Aug
€68.90
Loading
1Y
50.6%
7D
3.5%
Author's Valuation
€63.0
9.4% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€63.0
9.4% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-83m
4b
2014
2017
2020
2023
2025
2026
2028
Revenue €3.7b
Earnings €129.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.82%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.10%
Calculation
€129.91m
Earnings '28
x
10.42x
PE Ratio '28
=
€1.35b
Market Cap '28
€1.35b
Market Cap '28
/
18.76m
No. shares '28
=
€72.18
Share Price '28
€72.18
Share Price '28
Discounted to 2025 @ 6.09% p.a.
=
€60.45
Fair Value '25
